Mechanistic insight into digoxin inactivation by Eggerthella lenta augments our understanding of its pharmacokinetics.
about
The Woodrat Gut Microbiota as an Experimental System for Understanding Microbial Metabolism of Dietary ToxinsXenobiotics: Interaction with the Intestinal MicrofloraMicrobiology and ecology are vitally important to premedical curriculaHost-microbial interactions in the metabolism of therapeutic and diet-derived xenobiotics.Microbial determinants of biochemical individuality and their impact on toxicology and pharmacology.Stool metatranscriptomics: A technical guideline for mRNA stabilisation and isolation.Bidirectional interactions between indomethacin and the murine intestinal microbiotaSignatures of early frailty in the gut microbiotaThe microbial pharmacists within us: a metagenomic view of xenobiotic metabolismNutritional modulation of gut microbiota - the impact on metabolic disease pathophysiologyStool-based biomarkers of interstitial cystitis/bladder pain syndrome.Metabolomic Signatures for Drug Response Phenotypes: Pharmacometabolomics Enables Precision Medicine.Microbiome and metabolome data integration provides insight into health and disease.Gut microbiome interactions with drug metabolism, efficacy, and toxicity.Best practices for germ-free derivation and gnotobiotic zebrafish husbandry.A novel approach for the prediction of species-specific biotransformation of xenobiotic/drug molecules by the human gut microbiota.Mirror, mirror on the wall: which microbiomes will help heal them all?Biological Aging and the Human Gut Microbiota.Bile acids at the cross-roads of gut microbiome-host cardiometabolic interactions.Chemical reaction vector embeddings: towards predicting drug metabolism in the human gut microbiome.Remote Sensing between Liver and Intestine: Importance of Microbial Metabolites.The role of gut microbiota in the modulation of drug action: a focus on some clinically significant issues.Immunomodulatory interplay of the microbiome and therapy of rheumatic diseases.Genetic variants in cellular transport do not affect mesalamine response in ulcerative colitis.Making Millennial Medicine More Meta.Discovery and characterization of a prevalent human gut bacterial enzyme sufficient for the inactivation of a family of plant toxins.Predictive Modeling of Microbiome Data Using a Phylogeny-Regularized Generalized Linear Mixed Model.
P2860
Q26741802-B19DEA15-D8CC-47C4-B1E4-843348694018Q26795702-1388A5F3-7845-4050-9D53-678B1AC21B5EQ26801329-C9A56F64-67D1-4989-8C10-488D76EA1243Q34311685-1EFA6168-B028-455F-BA0F-41AE7E707B1CQ34615534-B37F18A7-8508-4663-A9E6-9A9C81358CE5Q35682285-E0972741-9E37-4341-B804-A2863F789701Q35878003-9BC57E35-1668-405F-A96C-65D6C0813013Q35907894-10786B09-719A-49FC-B267-C798F9852DB5Q35955534-8A30660E-8104-490C-8F81-28F409B96DBFQ36590565-63A554E9-1152-4406-BC11-13B930168832Q36910578-3218DB9A-9F78-40E3-BA12-F6261B538163Q37078812-21BDB3F3-96BD-4D87-A9F4-BBC72358ACB1Q38648247-229BFE90-01AD-4EF2-BA06-22F8121DB391Q38945423-F8F91B08-C773-48A6-963E-5C141AF34E9BQ41502485-EFCBCA8E-6D83-4E26-940B-EB859B6FE387Q41550197-A2C5FB18-14BC-4F20-9678-7C1A061982ADQ42562683-EBCF957A-9F62-442E-ABC6-03E2DD062128Q46376615-3516FD80-9ECC-4FBB-8E12-196E820709C8Q47134180-DD778ACC-84BB-4D03-B89F-E09D49CE00D2Q47345842-80CFC77E-CB0B-456B-944F-D2B23C4916E6Q49569061-ECB860E1-C04E-40FC-947E-363338ECE915Q50054146-FCF61980-2878-406C-AFDE-3307AEC565E9Q50067815-1769365B-327F-428E-A250-2EC40A1E7E42Q55029591-D9573632-D33F-4B8D-A9B7-74D1EBEAB38CQ55224879-DD292DE0-8A73-4368-A5F4-F113349780AAQ55375238-DA743C1A-CAFA-427D-8C0D-C2887AEA5393Q55711827-C4B5CD7F-4C3E-4A5A-9AAD-AFA8441C2239
P2860
Mechanistic insight into digoxin inactivation by Eggerthella lenta augments our understanding of its pharmacokinetics.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Mechanistic insight into digox ...... nding of its pharmacokinetics.
@ast
Mechanistic insight into digox ...... nding of its pharmacokinetics.
@en
type
label
Mechanistic insight into digox ...... nding of its pharmacokinetics.
@ast
Mechanistic insight into digox ...... nding of its pharmacokinetics.
@en
prefLabel
Mechanistic insight into digox ...... nding of its pharmacokinetics.
@ast
Mechanistic insight into digox ...... nding of its pharmacokinetics.
@en
P2093
P2860
P356
P1433
P1476
Mechanistic insight into digox ...... nding of its pharmacokinetics.
@en
P2093
Emily P Balskus
Henry J Haiser
Kristen L Seim
P2860
P304
P356
10.4161/GMIC.27915
P577
2014-01-23T00:00:00Z